Collaboration develops new compound with promising activity against SARS-CoV-2 variants

by

A collaboration between the Márquez group at EMBL Grenoble and Italian researchers from the European Biomedical Research Institute of Salerno (EBRIS) has led to the development and characterization of a novel small molecule inhibitor, which shows promising activity against three SARS-CoV-2 variants.

Leave A Comment

Your email address will not be published. Required fields are marked *